The Effects of 24 Weeks Community-based Brisk Walking on Physical Function, Comorbidities, Cognition, Disease Severity, and Health-related Quality of Life in People With Parkinson's Disease.

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to investigate if brisk walking can improve walking function in people with Parkinson's disease and what kind of brisk walking intervention that is most effective. The main questions are: If brisk walking can reduce self-perceived walking difficulty What type of exercise intervention is most effective. Researchers will compare a brisk walking group receiving a personalized walking program with a group receiving an activity tracker and a control group. Participants will * be tested at baseline (0 weeks), post the intervention period (24 weeks) and after a follow-up period (48 weeks). * be randomly allocated to one of three groups at baseline. * follow the prescribed intervention they are allocated to.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Healthy Volunteers: f
View:

• clinically diagnosed with Parkinson's disease

• aged ≥40 years

• Hoehn and Yahr stage ≤3

• able to independently undertake transportation back and forth from test days and training sessions

• expectedly able to complete ≥85% of the training sessions

• experience walking difficulties (the generic walking scale (Walk-12G) score ≥8.5).

Locations
Other Locations
Denmark
Aarhus University, Department of Public Health, Sport Science
RECRUITING
Aarhus C
Contact Information
Primary
Frederik B Jensen, MSc
fbj@ph.au.dk
+4521268252
Backup
Ulrik Dalgas, Professor
dalgas@ph.au.dk
Time Frame
Start Date: 2025-03-11
Estimated Completion Date: 2027-09-01
Participants
Target number of participants: 129
Treatments
Experimental: Combined individual home-based and supervised group-based walking exercise
43 people with Parkinsons disease would be randomly assigned to this experimental group. The group will receive the intervention WALK, that covers a personalized exercise program and group exercise session. It further covers the same as in the HOME group.
Active_comparator: Individual home-based exercise
43 people with Parkinsons disease would be randomly assigned to this active comparator group. The group receives the intervention (HOME) that covers an activity tracker and motivational telephone calls. It further covers the same as in the CON group.
Sham_comparator: Control group
43 people with Parkinsons disease would be randomly assigned to this sham comparator group. The group will only receive a short lecture in Parkinsons disease and exercise after completing the baseline test and allocated to the group.
Related Therapeutic Areas
Sponsors
Collaborators: Karolinska Institutet, Viborg Regional Hospital, Danish Parkinson Association, Fonden af 2. Juli 1984 til bekæmpelse af Parkinsons Sygdom, Denmark
Leads: University of Aarhus

This content was sourced from clinicaltrials.gov